PUBLISHED DATE : Mar 2021 | Pages : 319
Fill out your details & get your free sample
Single-use Bioprocessing Market Size, Share, Trends Analysis Report by Products (Single-use Bioprocessing Equipment and Simple & Peripheral Devices); Application (Monoclonal Antibodies (mABs), Vaccines, Cell Therapies, Others)); End-users (Biopharmaceutical Manufacturers, Contract Manufacturing Organizations (CMOs), R&D Companies & Research Institutes); Method (Filtration, Storage & Transport, Cell Culture, Mixing, Purification); and Geography (North America, Europe, APAC, Latin America, and Middle East & Africa); Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2021–2026
319 Pages
117 Tables
157 Charts
5 Regions
21 Countries
47 Companies
5 Market Segment
| Report Attribute | Details |
|---|---|
| MARKET SIZE (REVENUE) | 12 BILLION (2026) |
| CAGR | 17% (2021–2026) |
| Base Year | 2020 |
| Forecast Year | 2021–2026 |
| Market Segments | Products (Single-use Bioprocessing Equipment and Simple & Peripheral Devices); Application (Monoclonal Antibodies (mABs), Vaccines, Cell Therapies, Others)); End-users (Biopharmaceutical Manufacturers, Contract Manufacturing Organizations (CMOs), R&D Companies & Research Institutes); Method (Filtration, Storage & Transport, Cell Culture, Mixing, Purification) |
| Geographic Analysis | North America, Europe, APAC, Latin America, and Middle East & Africa |
| Countries Covered | US, Canada, UK, Switzerland, Germany, France, Italy, Spain, China, Japan, South Korea, Australia, India, Brazil, Mexico, Argentina, Columbia, Saudi Arabia, Turkey, South Africa, and UAE |
The global single-use bioprocessing market size was valued at USD 4.8 billion in 2020 and is expected to reach USD 12 billion in 2026, growing at a CAGR of 17% during the forecast period. The outbreak of the COVID-19 pandemic has boosted the demand for single-use bioprocessing technology.
The ongoing robust R&D activities and clinical studies on the Covid-19 vaccine encourage many stakeholders to use SUB technology. Modalities such as covid-19 vaccine requirement, cell and gene therapies, and monoclonal antibodies are likely to influence the single-use bioprocessing market growth. The majority of biomanufacturing companies rely on advanced technology such as single-use systems to develop the vaccine.
Single-use technology is primarily used in pre-commercial development activities, production phases, and small biotech manufacturing. Single-use solutions have already supplanted a significant portion of traditional biopharmaceutical manufacturing practices, and this trend is expected to increase in the coming years. The biopharmaceutical industry's shift from traditional stainless-steel bioprocessing equipment to single-use ones is majorly influenced by proven economic and operational benefits of single-use bioprocessing technology. The market is likely to observe significant growth as single-use technology is increasing in downstream bioprocessing.
This research report includes a detailed segmentation by
Single-use bioprocessing products observe growth due to advances in equipment, higher scalability, and the increased application in the biopharmaceutical industry. Bioreactors and fermenters cover significant shares among SUB. The use of bioreactors and fermenters is growing for the development of biosimilars & biologics. The availability of single-use chromatography systems is considered a solution for single-use downstream bioprocessing. The use of membrane formats, scaling technologies, ion exchange technology, and polymeric column constructions are shifting end-users toward SUBs in downstream processes. Chromatography systems combined with tangential flow filtrations provide the highest productivity in downstream separation and purification steps.
Simple & peripheral elements accounted for over 45% single-use bioprocessing market share. The recurring use of tubing and filling, connectors, bags, sampling devices, probes and sensors, bottle assemblies, and manifolds is responsible for these devices' growth. Connectors, filling and tubing, and filters occupy a significant portion of the market share. Single-use connectors and tubing are prioritized for advanced aseptic processing, enabling reliability, flexibility, and cost-efficiency. Biopharmaceutical and pharmaceutical industries are currently relying on single-use solutions for the upstream process. However, with recent advances and increased SUB penetration, end-users are likely to use single-use technologies for commercial purposes. As this equipment is single-use in nature, the sales of simple and peripheral devices are rapidly increasing, thereby increasing their revenue shares.
The increased application of monoclonal antibodies (mABs) to diagnose and treat autoimmune disorders, cancer, and sexually transmitted infections (STIs) is boosting the single-use bioprocessing market growth. The production of mABs via single-use bioreactors reduces the operating cost and offers more flexibility than traditional stainless steel equipment. Also, the use of SUB in mABs manufacturing increases capacity, productivity, and flexibility. The utilization of SUBs in vaccine manufacturing is catching pace and is considered the smart method, especially during pandemics. They have become an ideal choice among manufacturers as they can be manufactured quickly and do not require validation, and have a reduced risk of contamination. Furthermore, single-use systems help enhance flexibility in small and large vaccine manufacturing and produce multiple products in a single suite.
Vaccine manufacturing via SUB has shifted to a large scale due to the increasing demand for high capacities. With the outbreak of the covid-19 pandemic, single-use technology has emerged as a critical factor for the rapid production of the COVID-19 vaccine in a short time. In addition to covid-19 vaccine production, single-use technology is finding application in the manufacturing of other vaccines such as influenza, thereby influencing the market growth.
Biopharmaceutical manufacturers occupy a significant share of the market, with single-use systems witnessing adoption in pre-commercial production processes. Several biopharmaceutical manufacturers have started to explore these solutions in commercial manufacturing. However, their potential benefits are significant, particularly for small-volume manufacturing in modular facilities. With the advent of single-use bioprocessing, the bioprocessing industry's dynamics have changed, enabling companies to develop new biologics with higher flexibility and low upfront costs. As technology has become increasingly popular, many companies are becoming interested in the widespread adoption of single-use bioprocessing.
In 2020, contract manufacturing organizations (CMO) accounted for over 34% share in the single-use bioprocessing market. Currently, over 10% of bioprocessing worldwide - about 1.7 million liters rely on single-use systems. It is expected that single-use covers 25–30% of the bioprocessing market in the future. CMOs use more SUB than biopharmaceutical developers as they offer quick switching over process lines and increased flexibility. Moreover, CMOs implementing SUB are likely to save on operating costs, capital investments, and floor space & process lines.
Advances in the cell culture process and biopharmaceutical manufacturing are leading to the development of innovative single-use technology. Single-use bioreactors are increasingly used for animal and human cell production processes. SUBs in mammalian cell culture result in high flexibility, reduced cost, and enhanced product productivity. They are increasingly being used for small-batch, large-batch volumes, clinical trials, and process development.
Filtration contributes to over 30% shares of the market. The application of disposable products is increasing from downstream sterilization and purification to upstream depth filtration and clarification. Single-use systems are used in membrane absorption and viral clearance. Single-use depth filters are applied to clarify cell culture streams in the first step of the downstream process. The increased demand for advanced filtration techniques is growing with growing challenges in the downstream bioprocessing and improvements in the biomass concentration during biologics manufacturing.
North America and Europe constitute over 75% of the market share; however, the APAC region is expected to grow at the fastest CAGR of over 19% during 2020-2026. The increasing spending on biopharmaceutical research activities in the US and Canada, large-scale manufacturing facilities, and the growing demand for single-use technology contribute to the region's growth.
Similarly, in Europe, the increasing adoption of disposable bioprocessing, increasing biopharmaceutical manufacturing, and growing chronic diseases across Europe are significant drivers influencing the market growth. However, the APAC region is poised for growth. It is likely to grow at the fastest CAGR during the forecast period because of the growth in the R&D infrastructure, increase in the awareness of disposables, expiry of blockbuster biologics, favorable government initiatives, and increased demand for biologics.
Thermo Fisher Scientific, Sartorius Stedim Biotech, Merck KGaA, Danaher Corporation, and Avantor are the key vendors operating in the global single-use bioprocessing market. The key players are increasing their focus on mergers and acquisitions in the past few years. With the sudden onset of the COVID-19 pandemic, vendors target vaccine developers and offer customized and flexible SUB technology. Acquisitions of emerging/small, specialized single-use suppliers, product portfolio development, expansion in regional markets, and strengthening of global distribution networks are the major strategies adopted by vendors in the market.
Product
Application
End-users
Method
Geography
Frequently Asked Questions
How big is the single-use bioprocessing market?
The global single-use bioprocessing market size was valued at USD 4.8 billion in 2020 and is expected to reach USD 12 billion in 2026
What is the single-use bioprocessing market growth?
The SUB market is expected to grow at a CAGR of 17% during 2021-2026
What segments are covered in the Single-use Bioprocessing Market report?
This research report includes a detailed segmentation by, Product, Application, End-user, Method, Geography
Thermo Fisher Scientific, Sartorius Stedim Biotech, Danaher, Merck KGaA, and Avantor are the key players in the market. A selected life science businesses acquisition of Danaher Corporation by Sartorius Stedim Biotech on April 30, 2020 was a significant strategic acquisition, which is likely to complement the portfolio lineups of both Sartorius divisions.
Which region is likely to be the highest revenue generator in the market?
North America is expected to emerge as the largest revenue contributor to the market, expecting to cross approx. $5 billion.
High utilization of single-use bioprocessing for covid-19 vaccine production and the increasing adoption of single-use technologies over multi-use bioprocessing platforms are the major factors expecting to contribute to the market growth.
The global single-use bioprocessing market by revenue is expected to grow at a CAGR of 17% during 2021–2026.
The following factors are likely to contribute to the growth of the single-use bioprocessing market during the forecast period:
Base Year: 2020
Forecast Year: 2021–2026
The study considers the global single-use bioprocessing market’s present scenario and its market dynamics for 2020−2026. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent ones operating in the market.
Prominent Vendors
Other Prominent Vendors
Product
Application
End-users
Method
Geography
1 Research Methodology
2 Research Objectives
3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.2 Base Year
4.3 Scope of The Study
4.3.1 Market Segmentation By Product
4.3.2 Market Segmentation By Application
4.3.3 Market Segmentation By End-User
4.3.4 Market Segmentation By Method
4.3.5 Market Segmentation By Geography
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market at a Glance
7 Introduction
7.1 Overview
7.2 Single-Use Bioprocessing: Market Snapshot
8 Market Opportunities & Trends
8.1 Increasing Strategic Acquisitions & Partnerships
8.2 New Product Launches
8.3 High Utilization of Single-Use Bioprocessing For COVID-19 Vaccine Production
8.4 Technological Advances Witnessed In SUB
9 Market Growth Enablers
9.1 Increasing Adoption of Single-Use Technologies Over Multi-Use Platforms
9.2 Reduced Water Consumption and Lesser Environment Impact Of Single-Use Technologies
9.3 Lower Risk of Cross Contamination and Lower Manufacturing Cost
9.4 High Uptake of Biopharmaceuticals & Biosimilars
9.5 Increasing Demand for Flexible Bioprocessing And Less Floor Space Requirements
10 Market Restraints
10.1 Leachables & Extractables With Single-Use Bioprocessing
10.2 High-Cost of Single-Use Bioprocessing
10.3 Challenges With Scalability, Product Compatibility And Compliance
10.4 Regulatory Uncertainties Impacting the Adoption of Single-Use Bioprocessing
11 Market Landscape
11.1 Market Overview
11.1.1 Impact of COVID-19 on the Single-Use Bioprocessing Market
11.2 Market Size & Forecast
11.3 Five Forces Analysis
11.3.1 Threat of New Entrants
11.3.2 Bargaining Power of Suppliers
11.3.3 Bargaining Power of Buyers
11.3.4 Threat of Substitutes
11.3.5 Competitive Rivalry
12 Product
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 Single-Use Bioprocessing Equipment
12.3.1 Market Overview
12.3.2 Market Size & Forecast
12.4 Simple & Peripheral Elements
12.4.1 Market Overview
12.4.2 Market Size & Forecast
13 Application
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Monoclonal Antibodies
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.4 Vaccines
13.4.1 Market Overview
13.4.2 Market Size & Forecast
13.5 Cell Therapies
13.5.1 Market Overview
13.5.2 Market Size & Forecast
13.6 OTHERS
13.6.1 Market Overview
13.6.2 Market Size & Forecast
14 End-User
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Biopharmaceutical Manufacturers
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.4 CMOs
14.4.1 Market Overview
14.4.2 Market Size & Forecast
14.5 R&D Companies and Research Institutes
14.5.1 Market Overview
14.5.2 Market Size & Forecast
15 Method
15.1 Market Snapshot & Growth Engine
15.2 Market Overview
15.3 Filtration
15.3.1 Market Overview
15.3.2 Market Size & Forecast
15.4 Storage & Transport
15.4.1 Market Overview
15.4.2 Market Size & Forecast
15.5 Cell Culture
15.5.1 Market Overview
15.5.2 Market Size & Forecast
15.6 Mixing
15.6.1 Market Overview
15.6.2 Market Size & Forecast
15.7 Purification
15.7.1 Market Overview
15.7.2 Market Size & Forecast
16 Geography
16.1 Market Snapshot & Growth Engine
16.2 Geographic Overview
17 North America
17.1 Market Overview
17.2 Market Size & Forecast
17.3 Product Segmentation
17.4 Application Segmentation
17.5 End-User Segmentation
17.6 Key Countries
17.6.1 US: Market Size & Forecast
17.6.2 Canada: Market Size & Forecast
18 Europe
18.1 Market Overview
18.2 Market Size & Forecast
18.3 Product Segmentation
18.4 Application Segmentation
18.5 End-User Segmentation
18.6 Key Countries
18.6.1 Germany: Market Size & Forecast
18.6.2 France: Market Size & Forecast
18.6.3 Switzerland: Market Size & Forecast
18.6.4 UK: Market Size & Forecast
18.6.5 Italy: Market Size & Forecast
18.6.6 Spain: Market Size & Forecast
19 APAC
19.1 Market Overview
19.2 Market Size & Forecast
19.3 Product Segmentation
19.4 Application Segmentation
19.5 End-User Segmentation
19.6 Key Countries
19.6.1 China: Market Size & Forecast
19.6.2 Japan: Market Size & Forecast
19.6.3 Australia: Market Size & Forecast
19.6.4 South Korea: Market Size & Forecast
19.6.5 India: Market Size & Forecast
20 Latin America
20.1 Market Overview
20.2 Market Size & Forecast
20.3 Product Segmentation
20.4 Application Segmentation
20.5 End-User Segmentation
20.6 Key Countries
20.6.1 Brazil: Market Size & Forecast
20.6.2 Mexico: Market Size & Forecast
20.6.3 Colombia: Market Size & Forecast
20.6.4 Argentina: Market Size& Forecast
21 Middle East & Africa
21.1 Market Overview
21.2 Market Size & Forecast
21.3 Product Segmentation
21.4 Application Segmentation
21.5 End-User Segmentation
21.6 Key Countries
21.6.1 Turkey: Market Size & Forecast
21.6.2 Saudi Arabia: Market Size & Forecast
21.6.3 UAE: Market Size & Forecast
21.6.4 South Africa: Market Size & Forecast
22 COMPETITIVE LANDSCAPE
22.1 COMPETITION OVERVIEW
22.2 MARKET SHARE ANALYSIS
22.2.1 Thermo Fisher Scientific
22.2.2 Sartorius Stedim Biotech
22.2.3 Danaher
22.2.4 Merck KGaA
22.2.5 Avantor
23 Key Company Profiles
23.1 Thermo Fisher Scientific
23.1.1 Business Overview
23.1.2 Product Offerings
23.1.3 Key Strategies
23.1.4 Key Strengths
23.1.5 Key Opportunities
23.2 Sartorius Stedim Biotech
23.2.1 Business Overview
23.2.2 Product Offerings
23.2.3 Key Strategies
23.2.4 Key Strengths
23.2.5 Key Opportunities
23.3 Danaher
23.3.1 Business Overview
23.3.2 Product Offerings
23.3.3 Key Strategies
23.3.4 Key Strengths
23.3.5 Key Opportunities
23.4 MERCK KGaA
23.4.1 Business Overview
23.4.2 Product Offerings
23.4.3 Key Strategies
23.4.4 Key Strengths
23.4.5 Key Opportunities
23.5 Avantor
23.5.1 Business Overview
23.5.2 Product Offerings
23.5.3 Key Strategies
23.5.4 Key Strengths
23.5.5 Key Opportunities
24 Other Prominent Vendors
24.1 Applikon Biotechnology
24.1.1 Business Overview
24.1.2 Product Offerings
24.2 EPPENDORF
24.2.1 Business Overview
24.2.2 Product Offerings
24.3 CESCO Bioengineering
24.3.1 Business Overview
24.3.2 Product Offerings
24.4 Corning
24.4.1 Business Overview
24.4.2 Product Offerings
24.5 Rentschler Biopharma SE
24.5.1 Business Overview
24.5.2 Product Offerings
24.6 ENTEGRIS
24.6.1 Business Overview
24.6.2 Product Offerings
24.7 Meissner Filtration Products
24.7.1 Business Overview
24.7.2 Product Offerings
24.8 Parker-Hannifin Corporation
24.8.1 Business Overview
24.8.2 Product Offering
24.9 PBS Biotech
24.9.1 Business Overview
24.9.2 Product Offerings
24.10 Saint-Gobain
24.10.1 Business Overview
24.10.2 Product Offerings
24.11 Sentinel Process Systems
24.11.1 Business Overview
24.11.2 Product Offerings
24.12 ABEC
24.12.1 Business Overview
24.12.2 Product Offerings
24.13 ADOLF KÜHNER
24.13.1 Business Overview
24.13.2 Product Offerings
24.14 Charter Medical
24.14.1 Business Overview
24.14.2 Product Offerings
24.15 Holland Applied Technologies
24.15.1 Business Overview
24.15.2 Product Offerings
24.16 Repligen
24.16.1 Business Overview
24.16.2 Product Offerings
24.17 Solaris Biotech Solutions
24.17.1 Business Overview
24.17.2 Product Offerings
24.18 3M Company
24.18.1 Business Overview
24.18.2 Product Offerings
24.19 LONZA
24.19.1 Business Overview
24.19.2 Product Offerings
24.20 Pneumatic Scale Angelus
24.20.1 Business Overview
24.20.2 Product Offering
24.21 Artesyn Biosolutions
24.21.1 Business Overview
24.21.2 Product Offerings
24.22 Wego Group
24.22.1 Business Overview
24.22.2 Product Offerings
24.23 DISTEK
24.23.1 Business Overview
24.23.2 Product Offerings
24.24 New Horizon Biotech
24.24.1 Business Overview
24.24.2 Product Offerings
24.25 Omnibrx Biotechnologies
24.25.1 Business Overview
24.25.2 Product Offerings
24.26 YPOSKESI
24.26.1 Business Overview
24.26.2 Product Offering
24.27 Charge Point Technology
24.27.1 Business Overview
24.27.2 Product Offerings
24.28 High Purity New England
24.28.1 Business Overview
24.28.2 Product Offerings
24.29 Pendotech
24.29.1 Business Overview
24.29.2 Product Offerings
24.30 Advantapure
24.30.1 Business Overview
24.30.2 Product Offerings
24.31 TBL Performance Plastics
24.31.1 Business Overview
24.31.2 Product Offerings
24.32 CELLON
24.32.1 Business Overview
24.32.2 Product Offerings
24.33 SYSBIOTECH
24.33.1 Business Overview
24.33.2 Product Offerings
24.34 Broadley-James
24.34.1 Business Overview
24.34.2 Product Offerings
24.35 Cercell
24.35.1 Business Overview
24.35.2 Product Offerings
24.36 Presens-Precision Sensing
24.36.1 Business Overview
24.36.2 Product Offerings
24.37 Emerson Electric
24.37.1 Business Overview
24.37.2 Product Offerings
24.38 CPC
24.38.1 Business Overview
24.38.2 Product Offerings
24.39 Watson-Marlow Fluid Technology Group
24.39.1 Business Overview
24.39.2 Product Offerings
24.40 Foxx Life Sciences
24.40.1 Business Overview
24.40.2 Product Offerings
24.41 DRM
24.41.1 Business Overview
24.41.2 Product Offerings
24.42 W.L. Gore & Associates
24.42.1 Business Overview
24.42.2 Product Offerings
25 Report Summary
25.1 Key Takeaways
25.2 Strategic Recommendations
26 Quantitative Summary
26.1 Market by Product
26.1.1 SUB Equipment: Geography Segmentation
26.1.2 Simple & Peripheral Elements: Geography Segmentation
26.2 Market by Application
26.2.1 Monoclonal Antibodies: Geography Segmentation
26.2.2 Vaccines: Geography Segmentation
26.2.3 Cell Therapies: Geography Segmentation
26.2.4 Others: Geography Segmentation
26.3 Market by End-User
26.3.1 Biopharmaceutical Manufacturers: By Geography
26.3.2 CMOs: Geography Segmentation
26.3.3 R&D Companies and Research Institutes: Geography Segmentation
26.4 Market by Method
26.5 Market by Geography
26.5.1 North America: Product Segmentation
26.5.2 Europe: Product Segmentation
26.5.3 APAC: Product Segmentation
26.5.4 Latin America: Product Segmentation
26.5.5 Middle East & Africa: Product Segmentation
26.5.6 North America: Application Segmentation
26.5.7 Europe: Application Segmentation
26.5.8 APAC: Application Segmentation
26.5.9 Latin America: Application Segmentation
26.5.10 Middle East & Africa: Application Segmentation
26.5.11 North America: End-User Segmentation
26.5.12 Europe: End-User Segmentation
26.5.13 APAC: End-user Segmentation
26.5.14 Latin America: End-User Segmentation
26.5.15 Middle East & Africa: End-User Segmentation
27 Appendix
27.1 Abbreviations
List of Exhibits
Exhibit 1 Segmentation of Global Single-use Bioprocessing Market
Exhibit 2 Market Size Calculation Approach 2020
Exhibit 3 Impact of Increasing Strategic Acquisitions & Partnerships
Exhibit 4 Impact of New Product Launches
Exhibit 5 Areas of Interests in the New Product Development by Biotherapeutic Developers & CMOs
Exhibit 6 Impact of High Utilization of Single-use Bioprocessing for COVID-19 Vaccine Production
Exhibit 7 Long-term Effects of COVID-19 on Single-use Bioprocessing
Exhibit 8 Impact of Technological Advances Witnessed in SUB
Exhibit 9 Impact of Increasing Adoption of Single-use Technologies Over Multi-use Bioprocessing Platforms
Exhibit 10 Advantages of Single-use Bioprocessing
Exhibit 11 Comparison of Several Parameters for Single-use and Traditional Manufacturing Technology (%)
Exhibit 12 Usage of Single-use Bioprocessing by Developers and CMOs
Exhibit 13 Impact of Reduced Water Consumption and Lesser Environment Impact of Single-use Technologies
Exhibit 14 Comparison of Water and Energy Consumption by Single-use and Conventional Systems
Exhibit 15 Environmental Impact of Single-use and Traditional Biopharmaceutical Manufacturing Technology
Exhibit 16 Lifecycle Endpoint Impact of Single-use and Traditional Systems
Exhibit 17 Impact of Lower Risk of Cross Contamination and Lower Manufacturing Cost
Exhibit 18 Investment Cost Reduction Associated with Single-use Installation in Upstream Bioprocessing
Exhibit 19 Impact of High Uptake of Biopharmaceuticals & Biosimilars
Exhibit 20 Uptake of Biosimilars in Various Countries
Exhibit 21 Biologics Sales Worldwide (%)
Exhibit 22 Impact of Increasing Demand for Flexible Bioprocessing and Lesser Floor Space Requirements
Exhibit 23 Percentage of Space Reduction by Single-use Systems Compared with Traditional Systems
Exhibit 24 Impact of Leachables & Extractables with Single-use Bioprocessing
Exhibit 25 Concern of Leachables and Extractables by CMOs and Biotherapeutic Developers
Exhibit 26 Impact of High-Cost of Single-Use Bioprocessing
Exhibit 27 Percentage Restriction of SUS by CMOs and Biotherapeutic Developers
Exhibit 28 Reasons Obstructing the Usage of Single-use Bioprocessing
Exhibit 29 Impact of Challenges with Scalability, Product Compatibility and Compliance
Exhibit 30 Challenges Concerning Implementation of Single-Use Bioprocessing System
Exhibit 31 Impact of Regulatory Uncertainties Impacting the Adoption of Single-Use Bioprocessing
Exhibit 32 Global Single-use Bioprocessing Market 2020–2026 ($ million)
Exhibit 33 Global Single-use Bioprocessing Market by Geography
Exhibit 34 Global Single-use Bioprocessing Market by Product
Exhibit 35 Global Single-use Bioprocessing Market by Application
Exhibit 36 Global Single-use Bioprocessing Market by End-user
Exhibit 37 Global Single-use Bioprocessing Market by Method
Exhibit 38 Five Forces Analysis 2020
Exhibit 39 Incremental Growth by Product 2020 & 2026
Exhibit 40 Global Single-use Bioprocessing Market by Product
Exhibit 41 Global Single-use Bioprocessing Market by Product: Incremental Growth Comparison ($ million)
Exhibit 42 Global Single-use Bioprocessing Market by Product: Absolute Growth Comparison (%)
Exhibit 43 Global Single-use Bioprocessing Market by Single-use Bioprocessing Equipment 2020−2026 ($ million)
Exhibit 44 Global Single-use Bioprocessing Market by Simple & Peripheral Elements 2020-2026 ($ million)
Exhibit 45 Incremental Growth by Application 2020 & 2026
Exhibit 46 Global Single-use Bioprocessing Market by Application
Exhibit 47 Global Single-use Bioprocessing Market by Application: Incremental Growth Comparison ($ million)
Exhibit 48 Global Single-use Bioprocessing Market by Application: Absolute Growth Comparison (%)
Exhibit 49 Global Single-use Bioprocessing Market by Monoclonal Antibodies 2020–2026 ($ million)
Exhibit 50 Global Single-use Bioprocessing Market by Vaccines 2020–2026 ($ million)
Exhibit 51 Global Single-use Bioprocessing Market by Cell Therapies 2020–2026 ($ million)
Exhibit 52 Global Single-use Bioprocessing Market by Other Applications 2020−2026 ($ million)
Exhibit 53 Incremental Growth by End-User 2020 & 2026
Exhibit 54 Global Single-use Bioprocessing Market by End-user
Exhibit 55 Global Single-use Bioprocessing Market by End-user: Incremental Growth Comparison ($ million)
Exhibit 56 Global Single-use Bioprocessing Market by End-user: Absolute Growth Comparison (%)
Exhibit 57 Global Single-use Bioprocessing Market by Biopharmaceutical Manufacturers 2020−2026 ($ million)
Exhibit 58 Adoption of SUBs by CMOs and Biopharmaceutical Developers
Exhibit 59 Global Single-use Bioprocessing Market by CMOs 2020−2026 ($ million)
Exhibit 60 Global Single-use Bioprocessing Market by R&D Companies and Research Institutes 2020−2026 ($ million)
Exhibit 61 Incremental Growth by Method 2020 & 2026
Exhibit 62 Global Single-use Bioprocessing Market by Method
Exhibit 63 Global Single-use Bioprocessing Market by Method: Incremental Growth Comparison ($ million)
Exhibit 64 Global Single-use Bioprocessing Market by Method: Absolute Growth Comparison (%)
Exhibit 65 Global Single-use Bioprocessing Market by Filtration 2020−2026 ($ million)
Exhibit 66 Global Single-use Bioprocessing Market by Storage & Transport 2020−2026 ($ million)
Exhibit 67 Global Single-use Bioprocessing Market by Cell Culture 2020−2026 ($ million)
Exhibit 68 Global Single-use Bioprocessing Market by Mixing 2020−2026 ($ million)
Exhibit 69 Global Single-use Bioprocessing Market by Purification 2020−2026 ($ million)
Exhibit 70 Incremental Growth by Geography 2020 & 2026
Exhibit 71 Global Single-use Bioprocessing Market by Geography
Exhibit 72 Global Single-use Bioprocessing Market by Geography: Incremental Growth Comparison ($ million)
Exhibit 73 Global Single-use Bioprocessing Market by Geography: Absolute Growth Comparison (%)
Exhibit 74 Global Biopharmaceutical Manufacturing Facilities
Exhibit 75 Single-use Bioprocessing Market in North America 2020–2026 ($ million)
Exhibit 76 Incremental Growth by Product 2020 & 2026
Exhibit 77 Incremental Growth by Application 2020 & 2026
Exhibit 78 Incremental Growth by End-user 2020 & 2026
Exhibit 79 Incremental Growth in North America 2020 & 2026
Exhibit 80 Biopharmaceutical Research and Development Expenditure in US 2011 & 2019 ($ billion)
Exhibit 81 Comparison of Number of Biopharmaceutical Manufacturing Facilities in US, China, and India
Exhibit 82 Single-use Bioprocessing Market in US 2020–2026 ($ million)
Exhibit 83 Increasing Prevalence of Major Chronic Diseases in Canada
Exhibit 84 Cumulative Number of Biologics Approved by Health Canada 2015, 2017, & 2019
Exhibit 85 Single-use Bioprocessing Market in Canada 2020–2026 ($ million)
Exhibit 86 Comparison of Number of Approved Biosimilars in US and Europe
Exhibit 87 No. of Companies Involved in R&D Activities in the US, Europe & China
Exhibit 88 Single-use Bioprocessing Market in Europe 2020–2026 ($ million)
Exhibit 89 Incremental Growth by Product 2020 & 2026
Exhibit 90 Incremental Growth by Application 2020 & 2026
Exhibit 91 Incremental Growth by End-user 2020 & 2026
Exhibit 92 Incremental Growth in Europe 2020 & 2026
Exhibit 93 Prevalence of Chronic Diseases in Germany (%)
Exhibit 94 Global Biologics Delivered by Country (%)
Exhibit 95 Single-use Bioprocessing Market in Germany 2020−2026 ($ million)
Exhibit 96 Single-use Bioprocessing Market in France 2020−2026 ($ million)
Exhibit 97 Increasing Aging Demographics in Switzerland 2008, 2030, & 2045 (million)
Exhibit 98 Single-use Bioprocessing Market in Switzerland 2020−2026 ($ million)
Exhibit 99 Burden of Chronic Diseases in UK (%)
Exhibit 100 Single-use Bioprocessing Market in UK 2020−2026 ($ million)
Exhibit 101 Percentage Share of Chronic Diseases in Italy
Exhibit 102 High-research Intensive Biotechnological Industry in Italy
Exhibit 103 Single-use Bioprocessing Market in Italy 2020−2026 ($ million)
Exhibit 104 Prevalence of Chronic Diseases in the Spanish Population
Exhibit 105 Gross Domestic Research & Development Expenditure in Spain 2016 to 2019 (%)
Exhibit 106 Single-use Bioprocessing Market in Spain 2020−2026 ($ million)
Exhibit 107 Percentage of Deaths due to Chronic Diseases in South East Asia
Exhibit 108 Number of Biologics Patent Expiries and Sales at Risk from 2015–2030 ($ billion)
Exhibit 109 Single-use Bioprocessing Market in APAC 2020−2026 ($ million)
Exhibit 110 Incremental Growth by Product 2020 & 2026
Exhibit 111 Incremental Growth by Application 2020 & 2026
Exhibit 112 Incremental Growth by End-user 2020 & 2026
Exhibit 113 Incremental Growth in APAC 2020 & 2026
Exhibit 114 Prevalence Rates of Chronic Diseases in Rural Chinese Population
Exhibit 115 Research and Development Investment in China 2018 & 2019 ($ billion)
Exhibit 116 Single-use Bioprocessing Market in China 2020−2026 ($ million)
Exhibit 117 Prevalence of Chronic Diseases in Japan’s Elderly Population
Exhibit 118 Research & Development Expenditure in Japan by % Share GDP
Exhibit 119 Single-use Bioprocessing Market in Japan 2020−2026 ($ million)
Exhibit 120 Percentage Share of Aged 65 Years & Above Over Past Decade in Australia (%)
Exhibit 121 Single-use Bioprocessing Market in Australia 2020−2026 ($ million)
Exhibit 122 Percentage Prevalence of Disease Conditions in South Korea
Exhibit 123 Single-use Bioprocessing Market in South Korea 2020−2026 ($ million)
Exhibit 124 Percentage of Individuals Suffering from One or More Chronic Conditions by Age and Gender
Exhibit 125 Single-use Bioprocessing Market in India 2020−2026 ($ million)
Exhibit 126 Percentage of Aging Population in Latin America 2010−2050 (%)
Exhibit 127 Single-use Bioprocessing Market in Latin America 2020−2026 ($ million)
Exhibit 128 Incremental Growth by Product 2020 & 2026
Exhibit 129 Incremental Growth by Application 2020 & 2026
Exhibit 130 Incremental Growth by End-user 2020 & 2026
Exhibit 131 Incremental Growth in Latin America 2020 & 2026
Exhibit 132 Increasing Aging Population in Brazil from 2012 to 2050 (million)
Exhibit 133 Single-use Bioprocessing Market in Brazil 2020−2026 ($ million)
Exhibit 134 Estimated Increasing Trends in Breast and Lung Cancer in Mexicans
Exhibit 135 Single-use Bioprocessing Market in Mexico 2020−2026 ($ million)
Exhibit 136 Burden of Chronic NCDs in Colombia in Accordance with Age
Exhibit 137 Single-use Bioprocessing Market in Colombia 2020−2026 ($ million)
Exhibit 138 Growing Elderly Population from 2019 to 2100 in Argentina
Exhibit 139 Single-use Bioprocessing Market in Argentina 2020−2026 ($ million)
Exhibit 140 Number of Patient Population Suffering from Chronic Diseases in Middle East and Africa (million)
Exhibit 141 Single-use Bioprocessing Market in Middle East & Africa 2020−2026 ($ million)
Exhibit 142 Incremental Growth by Product 2020 & 2026
Exhibit 143 Incremental Growth by Application 2020 & 2026
Exhibit 144 Incremental Growth by End-user 2020 & 2026
Exhibit 145 Incremental Growth in Middle East & Africa 2020 & 2026
Exhibit 146 Prevalence of Chronic Kidney Disease Among Obese Population in Turkey
Exhibit 147 Single-use Bioprocessing Market in Turkey 2020−2026 ($ million)
Exhibit 148 Percentage Burden of Chronic Diseases in Saudi Arabia (%)
Exhibit 149 Single-use Bioprocessing Market in Saudi Arabia 2020−2026 ($ million)
Exhibit 150 Prevalence of Diabetes in UAE Based on Gender and Age
Exhibit 151 Single-use Bioprocessing Market in UAE 2020−2026 ($ million)
Exhibit 152 Prevalence of Various Chronic Diseases in South Africa
Exhibit 153 Single-use Bioprocessing Market in South Africa 2020−2026 ($ million)
Exhibit 154 Thermo Fisher Scientific Revenue 2017−2019 ($ million)
Exhibit 155 Thermo Fisher Scientific Revenue Share by Segments in FY2018 & 2019 ($ million)
Exhibit 156 Thermo Fisher Scientific Revenue Share by Region 2018 & 2019 ($ million)
Exhibit 157 Thermo Fisher Scientific R&D Investments from FY2017−2019 ($ million)
Exhibit 158 Sartorius Stedim Biotech Total Revenue from FY2017−2019 ($ million)
Exhibit 159 Sartorius Stedim Biotech R&D Investments 2017−2019 ($ million)
Exhibit 160 Sartorius Stedim Biotech Revenue Share by Regions 2018& 2019 ($ million)
Exhibit 161 Danaher Revenue FY2017−2019 ($ million)
Exhibit 162 Danaher Revenue Share by Segments in 2018 & 2019 ($ million)
Exhibit 163 Danaher Revenue Generated by Geographic Regions 2018 & 2019 ($ million)
Exhibit 164 Danaher R&D Investment 2017−2019 ($ million)
Exhibit 165 Merck KGaA Total Revenue Generated (FY2017−2019) ($ million)
Exhibit 166 Merck KGaA Revenue Generated by Segments in FY2018 & 2019 ($ million)
Exhibit 167 Merck KGaA Revenue Share by Regions 2018 & 2019 ($ million)
Exhibit 168 Merck KGaA R&D Investment FY2017−2019 ($ million)
Exhibit 169 Avantor Total Revenue FY2017−2019 ($ million)
Exhibit 170 Avantor Revenue Share by Segment based on Geography 2018& 2019 ($ million)
List Of Tables
Table 1 Key Caveats
Table 2 Currency Conversion 2013−2020
Table 3 Comparison of Single-use Bioprocessing & Traditional Stainless-steel Bioprocessing
Table 4 Key Strategic Acquisitions & Partnerships in Single-use Bioprocessing
Table 5 Companies Launching New Single-use Bioprocessing Products
Table 6 Difference between Single-use Manufacturing Facility & Conventional Stainless Manufacturing Facility
Table 7 Comparison of Single-use and Traditional Bioprocessing Systems
Table 8 Few Examples of Recent Approved Biologics and their Indications
Table 9 Facility Space Occupied by Stainless Steel and Single-use Systems (m2)
Table 10 Safety Concern of Final Product for Leachables/ Extractables
Table 11 Recent Advancements in Single-use Solutions
Table 12 Comparison of Single-use and Multi-use Bioreactors in terms of Process Time
Table 13 North America: Single-use Bioprocessing Market by Product 2020−2026 ($ million)
Table 14 North America: Single-use Bioprocessing Market by Product 2020−2026 (%)
Table 15 North America: Single-use Bioprocessing Market by Application 2020−2026 ($ million)
Table 16 North America: Single-use Bioprocessing Market by Application 2020−2026 (%)
Table 17 North America: Single-use Bioprocessing Market by End-user 2020−2026 ($ million)
Table 18 North America: Single-use Bioprocessing Market by End-user 2020−2026 (%)
Table 19 Europe: Single-use Bioprocessing Market by Product 2020−2026 ($ million)
Table 20 Europe: Single-use Bioprocessing Market by Product 2020−2026 (%)
Table 21 Europe: Single-use Bioprocessing Market by Application 2020−2026 ($ million)
Table 22 Europe: Single-use Bioprocessing Market by Application 2020−2026 (%)
Table 23 Europe: Single-use Bioprocessing Market by End-user 2020−2026 ($ million)
Table 24 Europe: Single-use Bioprocessing Market by End-user 2020−2026 (%)
Table 25 Currently Available Popular Biologics in APAC
Table 26 APAC: Single-use Bioprocessing Market by Product 2020−2026 ($ million)
Table 27 APAC: Single-use Bioprocessing Market by Product 2020−2026 (%)
Table 28 APAC: Single-use Bioprocessing Market by Application 2020−2026 ($ million)
Table 29 APAC: Single-use Bioprocessing Market by Application 2020−2026 (%)
Table 30 APAC: Single-use Bioprocessing Market by End-user 2020−2026 ($ million)
Table 31 APAC: Single-use Bioprocessing Market by End-user 2020−2026 (%)
Table 32 Few Examples of Recently Approved Biosimilars in Australia
Table 33 Patent Expirations of Few Original Biologics
Table 34 Few Examples of Approved Biosimilars in India and their Therapeutic Areas
Table 35 Some Available Biologics in Latin America
Table 36 Single-use Bioprocessing - New Product Launches
Table 37 Latin America: Single-use Bioprocessing Market by Product 2020−2026 ($ million)
Table 38 Latin America: Single-use Bioprocessing Market by Product 2020−2026 (%)
Table 39 Latin America: Single-use Bioprocessing Market by Application 2020−2026 ($ million)
Table 40 Latin America: Single-use Bioprocessing Market by Application 2020−2026 (%)
Table 41 Latin America: Single-use Bioprocessing Market by End-user 2020−2026 ($ million)
Table 42 Latin America: Single-use Bioprocessing Market by End-user 2020−2026 (%)
Table 43 Recently Launched Biosimilars in Middle East & Africa
Table 44 Middle East & Africa: Single-use Bioprocessing Market by Product 2020−2026 ($ million)
Table 45 Middle East & Africa: Single-use Bioprocessing Market by Product 2020−2026 (%)
Table 46 Middle East & Africa: Single-use Bioprocessing Market by Application 2020−2026 ($ million)
Table 47 Middle East & Africa: Single-use Bioprocessing Market by Application 2020−2026 (%)
Table 48 Middle East & Africa: Single-use Bioprocessing Market by End-user 2020−2026 ($ million)
Table 49 Middle East & Africa: Single-use Bioprocessing Market by End-user 2020−2026 (%)
Table 50 Global Single-use Bioprocessing Market: Vendors Ranking
Table 51 Thermo Fisher Scientific: Major Product Offerings
Table 52 Sartorius Stedim Biotech: Major Product Offerings
Table 53 Danaher: Major Product Offerings
Table 54 Merck KGaA: Major Product Offerings
Table 55 Avantor: Major Product Offerings
Table 56 Applikon Biotechnology: Major Product Offerings
Table 57 Eppendorf: Major Product Offerings
Table 58 CESCO Bioengineering: Major Product Offerings
Table 59 Corning: Major Product Offerings
Table 60 Rentschler Biopharma SE: Major Product Offerings
Table 61 Entegris: Major Product Offerings
Table 62 Meissner Filtration Product: Major Product Offerings
Table 63 Parker-Hannifin Corporation: Major Product Offerings
Table 64 PBS Biotech: Major Product Offerings
Table 65 Saint-Gobain: Major Product Offerings
Table 66 Sentinel Process Systems: Major Product Offerings
Table 67 ABEC: Major Product Offerings
Table 68 Adolf Kühner: Major Product Offerings
Table 69 Charter Medical: Major Product Offerings
Table 70 Holland Applied Technologies: Major Product Offerings
Table 71 Repligen: Major Product Offerings
Table 72 Solaris Biotech Solutions: Major Product offerings
Table 73 3M Company: Major Product Offerings
Table 74 Lonza: Major Product Offerings
Table 75 Pneumatic Scale Angelus: Major Product Offerings
Table 76 ARTeSYN Biosolutions: Major Product Offerings
Table 77 Wego Group: Major Product Offerings
Table 78 Distek: Major Product Offerings
Table 79 New Horizon Biotech: Major Product Offerings
Table 80 OmniBRx Biotechnologies: Major Product Offerings
Table 81 Yposkesi: Major Product Offerings
Table 82 Charge Point Technologies: Major Product Offerings
Table 83 High Purity New England: Major Product Offerings
Table 84 PendoTECH: Major Product Offerings
Table 85 AdvantaPure: Major Product Offerings
Table 86 TBL Performance Plastics: Major Product Offerings
Table 87 Cellon: Major Product Offerings
Table 88 Sysbiotech: Major Product Offerings
Table 89 Broadley-James: Major Product Offerings
Table 90 CerCell: Major Product Offerings
Table 91 PreSens-Precision Sensing: Major Product Offerings
Table 92 Emerson Electric: Major Product Offerings
Table 93 CPC: Major Product Offerings
Table 94 Watson-Marlow Fluid Technology Group: Major Product Offerings
Table 95 Foxx Life Sciences: Major Product Offerings
Table 96 DRM: Major Product Offerings
Table 97 W.L. Gore & Associates: Major Product Offerings
Table 98 Global Single-use Bioprocessing Market by Product 2020−2026 ($ million)
Table 99 Global Single-use Bioprocessing Market by Product 2020−2026 (%)
Table 100 Single-use Bioprocessing Equipment by Geography 2020−2026 ($ million)
Table 101 Single-use Bioprocessing Equipment by Geography 2020−2026 (%)
Table 102 Simple & Peripheral Elements by Geography 2020−2026 ($ million)
Table 103 Simple & Peripheral Elements by Geography 2020−2026 (%)
Table 104 Global Single-use Bioprocessing Market by Application 2020−2026 ($ million)
Table 105 Global Single-use Bioprocessing Market by Application 2020−2026 (%)
Table 106 Monoclonal Antibodies by Geography 2020−2026 ($ million)
Table 107 Monoclonal Antibodies by Geography 2020−2026 (%)
Table 108 Vaccines by Geography 2020−2026 ($ million)
Table 109 Vaccines by Geography 2020−2026 (%)
Table 110 Cell Therapies by Geography 2020−2026 ($ million)
Table 111 Cell Therapies by Geography 2020−2026 (%)
Table 112 Others by Geography 2020−2026 ($ million)
Table 113 Others by Geography 2020−2026 (%)
Table 114 Global Single-use Bioprocessing by End-user 2020−2026 ($ million)
Table 115 Global Single-use Bioprocessing by End-user 2020−2026 (%)
Table 116 Biopharmaceutical Manufacturers by Geography 2020−2026 ($ million)
Table 117 Biopharmaceutical Manufacturers by Geography 2020−2026 (%)
Table 118 CMOs by Geography 2020−2026 ($ million)
Table 119 CMOs by Geography 2020−2026 (%)
Table 120 R&D Companies and Research Institutes by Geography 2020−2026 ($ million)
Table 121 R&D Companies and Research Institutes by Geography 2020−2026 (%)
Table 122 Global Single-use Bioprocessing Market by Method 2020−2026 ($ million)
Table 123 Global Single-use Bioprocessing Market by Method 2020−2026 (%)
Table 124 Global Single-use Bioprocessing Market by Geography 2020−2026 ($ million)
Table 125 Global Single-use Bioprocessing Market by Geography 2020−2026 (%)
Table 126 North America by Product 2020−2026 ($ million)
Table 127 North America by Product 2020−2026 (%)
Table 128 Europe by Product 2020−2026 ($ million)
Table 129 Europe by Product 2020−2026 (%)
Table 130 APAC by Product 2020−2026 ($ million)
Table 131 APAC by Product 2020−2026 (%)
Table 132 Latin America by Product 2020−2026 ($ million)
Table 133 Latin America by Product 2020−2026 (%)
Table 134 Middle East & Africa by Product 2020−2026 ($ million)
Table 135 Middle East & Africa by Product 2020−2026 (%)
Table 136 North America by Application 2020−2026 ($ million)
Table 137 North America by Application 2020−2026 (%)
Table 138 Europe by Application 2020−2026 ($ million)
Table 139 Europe by Application 2020−2026 (%)
Table 140 APAC by Application 2020−2026 ($ million)
Table 141 APAC by Application 2020−2026 (%)
Table 142 Latin America by Application 2020−2026 ($ million)
Table 143 Latin America by Application 2020−2026 (%)
Table 144 Middle East & Africa by Application 2020−2026 ($ million)
Table 145 Middle East & Africa by Application 2020−2026 (%)
Table 146 North America by End-user 2020−2026 ($ million)
Table 147 North America by End-user 2020−2026 (%)
Table 148 Europe by End-user 2020−2026 ($ million)
Table 149 Europe by End-user 2020−2026 (%)
Table 150 APAC by End-user 2020−2026 ($ million)
Table 151 APAC by End-user 2020−2026 (%)
Table 152 Latin America by End-user 2020−2026 ($ million)
Table 153 Latin America by End-user 2020−2026 (%)
Table 154 Middle East & Africa by End-user 2020−2026 ($ million)
Table 155 Middle East & Africa by End-user 2020−2026 (%)
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
